Dr. Reddy's Laboratories LimitedRDYNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P36
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -34.02% |
| Q3 2025 | 21.33% |
| Q2 2025 | -58.31% |
| Q1 2025 | 588.86% |
| Q4 2024 | -256.29% |
| Q3 2024 | -32.09% |
| Q2 2024 | 2742.11% |
| Q1 2024 | 924.39% |
| Q4 2023 | -99.95% |
| Q3 2023 | 1618.68% |
| Q2 2023 | -105.78% |
| Q1 2023 | -20.98% |
| Q4 2022 | 238.73% |
| Q3 2022 | 392.48% |
| Q2 2022 | -139.96% |
| Q1 2022 | -60.40% |
| Q4 2021 | 710.78% |
| Q3 2021 | 68.98% |
| Q2 2021 | -6073.56% |
| Q1 2021 | 481.89% |
| Q4 2020 | -99.70% |
| Q3 2020 | -27.08% |
| Q2 2020 | 50796.47% |
| Q1 2020 | -99.70% |
| Q4 2019 | -32.91% |
| Q3 2019 | 6.11% |
| Q2 2019 | 55.62% |
| Q1 2019 | -62.95% |
| Q4 2018 | 69.44% |
| Q3 2018 | 217.22% |
| Q2 2018 | -277.29% |
| Q1 2018 | -1.10% |
| Q4 2017 | 12.67% |
| Q3 2017 | 173.64% |
| Q2 2017 | -197.54% |
| Q1 2017 | 141.92% |
| Q4 2016 | 108.89% |
| Q3 2016 | -775.98% |
| Q2 2016 | -148.16% |
| Q1 2016 | -20.47% |